All

Results: 21925-21936 of 77484

Stockholm hospitals unify all imaging in Sectra's cloud service to boost collaboration and patient care

PR Newswire associated0

Capita launches The AI Catalyst Stack in drive to become the first AI-Enabled BPO

PR Newswire associated0

Best Deal to You. Best Gift to the Planet: Jackery partners with Greenspark this Black Friday to turn great deals into real climate action

Business Wire associated0

Airborne Capital Agrees Second Lease with Geosky Airlines

PR Newswire associated0

Yas Island Abu Dhabi to Open 'Stranger Things: The Experience'

Appointments to Aktia Bank Plc's Executive Committee

PR Newswire associated0

HOW2WORK and SAKA SAKA Partner for the Global Launch (exclude Mainland China) HOW2WORK Collectible Trading Cards: The Monsters Series 3 by Kasing Lung

ASSA ABLOY acquires Metal Products Inc. in the US

PR Newswire associated0

Envision Energy Rolls Out Gen 8 Scalable Platform: Higher Energy Density, Greater Flexibility, Elevated Returns

PR Newswire associated0

Taiwan Showcases Asia-Pacific Leadership in Circular Economy at APCER & Hotspot 2025

PR Newswire associated0

Hikvision hosts 2025 HikTech Star Tour to strengthen connections with tech partners

Professor Nguyen Thanh Liem, Director, Institute of Stem Cell and Genetic Technology Research at Vinmec International Hospital, Hanoi, Vietnam and his team have successfully implemented the technology transfer of Autologous Immune Enhancement Therapy (AIET) from Japan and demonstrated its safety and efficacy as an adjuvant in combination with standard of care in various cancers. Prof. Liem, a renowned pediatric surgeon and pioneer in regenerative medicine, has received numerous prestigious honors, including the 2018 Nikkei Asia Prize for Science & Technology, the Ho Chi Minh Prize, the Hero of Labor Medal, and the Vietnamese Talent Award. In 2025, he was named among the world's most influential scientists by a Stanford University, USA research group. Driven by a passion to improve cancer patients’ quality of life, Prof. Liem successfully brought AIET to Vietnam in 2018 transferred by GN Corporation, Japan, technically supported by Nichi-In Centre for Regenerative Medicine (NCRM)

Colorectal, Liver, and Lung Cancer Patients at Vinmec Experience Extended Survival with AIET Cell-Based Immunotherapy – Technology Transferred from Japan